Nigeria
NAFDAC- Pathway & reliance
- Full assessment; reliance on WHO PQ & SRA/WLA; collaborative initiatives
- Indicative timeline
- ~12–18 months
- Local presence
- Required
- Language
- English
Entering African markets means navigating a different authority, framework, and timeline in every country. Here is a clear, country-by-country starting point — the regulator, the pathway, the timelines, and the local obligations that determine whether you can submit at all.
Note Requirements, timelines, and fees evolve rapidly as AMA, AMRH, and regional harmonization advance. The information below is indicative and updated periodically; we confirm current requirements for every active engagement.
ECOWAS · WAHO · UEMOA
Additional profiles on request: Burkina Faso, Mali, Togo, Niger, Guinea.
CEMAC · ECCAS (CEEAC)
Additional profiles on request: Central African Republic, Equatorial Guinea, DR Congo.
Regional frameworks at a glance
Two integration layers increasingly shape these markets. In West Africa, ECOWAS — through WAHO and, for the Francophone states, UEMOA — is driving harmonization, while ZaZiBoNa-style collaborative registration expands. In Central Africa, CEMAC and ECCAS advance pharmaceutical harmonization. Above both sits the African Medicines Agency (AMA), which over time will enable continental scientific opinions and stronger reliance.
Request a market-entry assessment — including the fastest compliant pathway and reliance options for your product.